These results highlight the significant benefits of adding tirzepatide to insulin therapy, offering improved glycemic control and meaningful weight loss in patients with T2DM who are inadequately controlled on insulin glargine alone [72]
Temporary GLP-1 use suits patients with moderate weight loss goals, strong motivation for lifestyle change, and no underlying metabolic conditions that drive continuous appetite dysregulation
While studying GLP-1s and how effectively they treat diabetes, researchers discovered how significantly these medications can also affect a persons appetite, satiety, and food intake
If not addressed, stomach paralysis may lead to malnutrition, dehydration, and blood sugar complications
The composition of tap waterincluding minerals such as calcium and magnesiumdoes not contain the nutrient signals necessary to stimulate incretin hormone release